Search

Your search keyword '"Kabwigu, Samuel"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Kabwigu, Samuel" Remove constraint Author: "Kabwigu, Samuel"
37 results on '"Kabwigu, Samuel"'

Search Results

1. Social harms in female-initiated HIV prevention method research: state of the evidence.

2. Factors associated with uptake and acceptability of cervical cancer screening among female sex workers in Northeastern Uganda: A cross-sectional study.

3. Female Genital Tract Host Factors and Tenofovir and Lamivudine Active Metabolites.

4. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

9. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

10. Depot Medroxyprogesterone Acetate and the Vaginal Microbiome as Modifiers of Tenofovir Diphosphate and Lamivudine Triphosphate Concentrations in the Female Genital Tract of Ugandan Women: Implications for Tenofovir Disoproxil Fumarate/Lamivudine in Preexposure Prophylaxis

11. Impact of Male Partner Involvement on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial.

12. Depot Medroxyprogesterone Acetate and the Vaginal Microbiome as Modifiers of Tenofovir Diphosphate and Lamivudine Triphosphate Concentrations in the Female Genital Tract of Ugandan Women: Implications for Tenofovir Disoproxil Fumarate/Lamivudine in Preexposure Prophylaxis

14. Implementation of a prospective pregnancy registry for antiretroviral based HIV prevention trials

15. HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial

19. The MTN-016 Pregnancy Registry: Baseline Characteristics of Enrollees from the VOICE Study and Reasons for Non-enrollment of Eligible Women

22. Hematologic and Chemistry Normal Laboratory Values among Healthy Ugandan Women Screened for a Pre-exposure Prophylaxis Trial: The MTN-003(VOICE) Study

26. Recruitment for Retention in Biomedical HIV Prevention Studies: Strategies, Challenges, Lessons Learned from MTN-020 (ASPIRE) Study, at Kampala Site

27. Obstetric and Infant Outcomes Following Planned Maternal Third Trimester Exposure to Tenofovir 1% Vaginal Gel.

28. Maximizing Participant Retention in a Phase2 B HIV Prevention Trial in Kampala, Uganda: The MTN-003 (VOICE Study).

29. Why Women at High Risk for HIV-1 Infection Did Not Join the VOICE Study in Uganda: A Qualitative Community Study.

30. How Community Education Tools Facilitated Understanding of the ASPIRE Vaginal Ring Study: Kampala Experience.

31. Hematologic and Chemistry Normal Laboratory Values among Healthy Ugandan Women Screened for a Pre-exposure Prophylaxis Trial: The MTN-003(VOICE) Study.

32. To Give or Not to Give PK Results: An Ethical Dilemma for Researchers & Regulators in Uganda.

33. Recruitment for Retention in Biomedical HIV Prevention Studies: Strategies, Challenges, Lessons Learned from MTN-020 (ASPIRE) Study, at Kampala Site.

34. Strategies for Successful Promotion and Implementation of Contraceptive Method Mix in MTN-020/ASPIRE: The Why and How at Kampala Site.

35. Impact of DSMB Outcomes on Participation in HIV Prevention Trials: The VOICE Study Experience in Kampala, Uganda.

36. Implementation of a prospective pregnancy registry for antiretroviral based HIV prevention trials.

37. Case Study: Converting Paper-based Case Report Forms to an Electronic Format (e-CRF) with ACASI Self-Report Integration.

Catalog

Books, media, physical & digital resources